The Most Favoured Nation (MFN) trade policy is reshaping India’s pharmaceutical industry by enabling smoother supply chains and expanding global market access. Through reduced tariffs and equal trade terms, India is strengthening its position as a leading supplier of affordable medicines worldwide, while facing new opportunities and challenges in an increasingly competitive landscape.

Recent political tensions between India and Pakistan have severely disrupted bilateral trade, impacting exporters and importers across key sectors. This article explores the complex challenges faced by businesses, especially SMEs, and highlights how expert international business consulting and strategic market entry planning can help navigate these turbulent times.